HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging

Signup
Browse Studies

City:   Richmond
State:   Virginia
Zip Code:   23284
Conditions:   Aging
Purpose:   This study will examine the role of epigenetics (heritable changes in gene function that occur without a change in DNA sequence) in the aging process. DNA is the primary genetic material, responsible for transmitting information from one cell to the next or from one generation to the next. A second layer of heredity is described by the term "epigenetics." Epigenetic information is reset from one generation to the next. It works in two ways: 1) by modification of the DNA, like balloons stuck at irregular intervals onto the sides of the DNA helix that encodes genes, and 2) through specialized protein shells that wrap around some regions of DNA. As in DNA, these shells can copy themselves and can transmit instructions. Because they are used to turn genes on and off, errors in their settings cause critical misinformation to be transmitted. Aging involves many changes, such as muscle weakening, graying hair, skin wrinkling, and so forth. There are several current theories of aging, including damage to genes by oxidation, shortening of tiny structures at the ends of chromosomes called telomeres, and the ability to stretch lifespan with caloric restrictions. This study will investigate the possible role of epigenetics in aging by examining and comparing the shell-like epigenetic settings in skin cells in young adults and older individuals. Preliminary results from earlier studies show differences in these settings in younger and older people. Women between the ages of 21 and 30 years and 65 and 90 years who are undergoing breast reduction or mastectomy at Suburban Hospital in Bethesda, Maryland, may participate in this study. Tissue removed during surgery for pathological examination will also be used by researchers in this study to validate the preliminary findings noted above and to continue studies into the new area of epigenetics and aging.
Study Summary:   Normal human lifespan is marked by a complex series of developmental events, relative stability during adulthood, and ultimately a gradual decline in viability. Biological clocks presumably underlie the developmental events that occur through childhood and adolescence, but the nature of those clocks has remained obscure. Progress in this area would be of considerable importance, not only for our understanding of child development, but also because instability in putative clock-like mechanisms may occur as part of the aging process. Such instability could well compromise tissue function and contribute to many of the common degenerative diseases of later life. We propose to investigate whether developmental clocks and related aspects of the aging process are attributable in part to age-related epigenome remodeling. Experiments done to date with cultured human fibroblasts derived from tissue banks provide tentative support for this hypothesis. To exclude tissue culture-related artifacts and to continue the work, it is essential to have access to fresh tissue material in the form of surgically obtained skin specimens that would otherwise be discarded. Elective breast reduction mammoplasty is a frequently performed surgery at Suburban Hospital, Bethesda, Maryland. Small skin specimens will be obtained from this procedure, as well as from normal skin derived from mastectomies. Patients who are to undergo these procedures will be asked to sign a consent form allowing the specimens, normally discarded, to be used instead for research on the mechanism of aging. They will be informed that clinical information will accompany the specimens, including age and known disease conditions. Twenty patients in each of two age ranges, 21-30 yr and 65-90 yr, will be enrolled in the study. The primary outcome will be confirmation of age-related epigenome change in the chromosome 4q35.2 region, previously documented using tissue bank-derived cultured skin fibroblasts. Mapping and sampling chromatin from this region revealed higher histone H4 acetylation in young (24-30 yr) than old (80-85 yr) individuals. Confirmation of this change in primary fibroblasts will be followed by more detailed mapping of chromatin structure and extension beyond the currently defined limits. Secondary outcomes will include examination of two areas of epigenome remodeling that appear to occur between birth and adulthood, as well as searches for additional regions of age-related chromatin change.
Criteria:   - INCLUSION CRITERIA: Age 21-30 or 65-90, female or male Normal liver function, renal function adjusted for age Written informed consent EXCLUSION CRITERIA: Down's or other premature aging syndromes Mastectomies: skin involvement in the malignant process or damage due to prior radiation therapy Active skin infection Skin damage due to photoaging will be noted but will not be a basis for exclusion
NCT ID:   NCT00242255
Primary Contact:   Principal Investigator
Bruce H Howard, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Bruce H Howard, M.D.
Phone: (301) 496-9038
Email: howardb@mail.nih.gov
Backup Contact:   N/A
Location Contact:   Richmond, Virginia 23284
United States



There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   June 19, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Emphysema/COPD (Chronic Obstructive Pulmonary Disease) - Richmond VA

Pediatric Depression - Richmond VA

Polycystic Ovary Syndrome - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

Chronic Obstructive Pulmonary Disorder (COPD) - Richmond VA

Eczema - Henrico VA

Type 2 Diabetes - Richmond VA

Pediatric Depression - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA

Asthma - Henrico VA

Within 50 Miles

Within 100 Miles

Restless Legs Syndrome (RLS) - Charlottesville VA

Dry Eye - Norfolk VA

Anti-Depressant Induced Sexual Dysfunction - Washington DC

Anti-Depressant Induced Sexual Dysfunction - Charlottesville VA

Arthritis - Manassas VA

Postherpetic Neuralgia (Post-shingles pain) - Herndon VA

COPD (Emphysema and Chronic Bronchitis) - Norfolk VA

Pediatric Migraines (Ages 12-17) - Charlottesville VA

Osteoartritis of the Hands - Norfolk VA

Osteoartritis of the Hands - Charlottesville VA

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.